Bryan Ball
Förmögenhet: 1 M $ per 2026-10-31
Förmögenhet: 1 M $ per 2026-10-31
Bryan Ball is currently Chief Technical Operations Officer at Whitehawk Therapeutics, Inc. since 2024.
Former positions include Chief Quality Officer at Immunomedics, Inc., Chief Quality Officer & Senior VP-Operations at Intercept Pharmaceuticals, Inc. from 2021 to 2022, Vice President-Global Quality at Ikaria, Inc. from 2012 to 2015, Vice President-Quality & Regulatory at Ben Venue Laboratories, Inc., and SVP-Global Quality, Environmental Health & Safety at Mallinckrodt LLC from 2015 to 2019.
Education includes undergraduate studies at Central Michigan University, an MBA from Westminster School, and graduate studies at The University of North Carolina at Charlotte.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-15 | 448 126 ( 0,95 % ) | 1 M $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-03-01 |
| Företag | Position | Slut |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Verksamhetschef | 2022-08-01 |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Företagsledare/Principal | 2019-01-01 |
| IKARIA, INC. | Företagsledare/Principal | 2015-01-01 |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Företagsledare/Principal | - |
| IMMUNOMEDICS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Health Technology |
Central Michigan University
Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westminster School
Westminster School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Aadi Bioscience, Inc.
Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån